[The effectiveness of eradication therapy of the 1st line of Helicobacter pylori infection in patients with type 2 diabetes mellitus].
Igor MaevAshot M MkrtumyanL G BektemirovaDmitrii N AndreevD T DichevaPublished in: Terapevticheskii arkhiv (2022)
The data of the study of the efficacy and safety of line I eradication therapy make it possible to recommend the four-component therapy based on bismuth for use in clinical practice, especially in patients with DM.